For nearly three decades, Mayo Clinic researcher Christopher Evans, Ph.D., has pushed to expand gene therapy beyond its ...

Madrigal Pharmaceuticals said on Wednesday it has entered into a licensing agreement worth up to $2 billion with China's CSPC Pharmaceutical Group to develop an oral GLP-1 drug for a serious form of ...

Thousands find weight loss relief on Zepbound. Now, they face a choice: Try a different medicine that may have adverse side effects or stop treatment.

SaveHealth reports migraines are complex neurological conditions affecting over a billion globally, requiring comprehensive ...

U.S. health officials are warning Americans about the risks of an opioid-related ingredient added to energy drinks, gummies and supplements sold at gas stations and convenience stores, recommending a ...

In their zeal to "Make America Healthy Again," top Trump administration officials depict patients and the doctors who treat ...

For decades, the idea that food could be addictive was considered fringe. In 2017, when Gearhardt presented her research at a ...

Madrigal Pharmaceuticals said on Wednesday it has entered into an up to $2 billion global license agreement with CSPC Pharmaceutical to develop an oral GLP-1 drug for a type of liver disease.

Vitamin D supplements help to fill the gaps, but that can come at a cost if they’re taken with certain medications. “Like any ...

In terms of drug class, immunosuppressants hold the largest market share, accounting for 42.10% in 2024. Their effectiveness ...

Shareholders sued over what they saw as a breach of fiduciary duties by the board of directors regarding the drug Anktiva, ...